SPRING Singapore (Standards, Productivity and Innovation Board) and the Economic Development board launched Singapore’s first efforts to standardize the country’s medical devices industry on January 17, 2003. The standard proposed by the governing authorities is called the Technical Reference for Medical Device... Read More
The Singaporean government has been stepping up its efforts to build the country into a biotechnology hub. With more than S$3 billion (US$ 1.7 billion) set aside for development of biomedical sciences in Singapore over the next five years, Singapore’s Economic Development... Read More
Certification is often required in many countries for designated products such as electronics and medical devices. Regulated products cannot be sold without certification marks if they have been designated as “compulsory certification products.” Product certification marks are used to inform consumers of... Read More
Singapore’s Economic Review Committee recently released a report outlining its recommendations to lift the 3% goods and services tax that is currently levied on healthcare services within the country. Should the proposed tax lifting be implemented, both foreign and local users of... Read More
The Singaporean Ministry of Health (MOH) announced on August 20, 2002, that they are implementing new regulatory controls over Chinese proprietary medicines (CPMs). Due to the rise of recent health related problems as a result of CPM consumption, the Ministry is tightening... Read More
Slowing economies have not stopped Asian countries from moving ahead with medical device regulatory reforms. Asian consumers demand high-quality healthcare products, making it worthwhile for American manufactures to be active in the region. Procedures and practices vary according to country. This article... Read More
The Singapore government has set aside another S$25 million (US$14.3 million) to distribute to promising companies in the life-sciences industry. Singapore’s Economic Development Board has already spent in excess of S$150 million (US$86 million) in 50 portfolio companies. The money will come... Read More
Scientists in Singapore will be allowed to withdraw stem cells from adult human tissues, aborted fetuses, and surplus embryos less than 14 years old for research purposes, according to new guidelines approved by the Central Government July 17, 2002. The cloning of... Read More
A recent report by the accounting firm, Ernst & Young, finds an increase in the amount of investment by governments in the Asia-Pacific region in biotechnology. Besides investment incentives and tax breaks, governments have begun to nurture the fledgling industry with increased... Read More
The regulatory system for medical device registration in Singapore is changing. On April 1, 2001, changes in regulations as well as a new statutory board were announced. The new agency, called the Health Sciences Authority (HSA), aims to provide a “one-stop, multi-disciplinary... Read More